Conduit Pharmaceuticals Inc. (NASDAQ:CDTTW) Short Interest Update

Conduit Pharmaceuticals Inc. (NASDAQ:CDTTW) was the recipient of a significant decrease in short interest during the month of October. As of October 31st, there was short interest totalling 36,800 shares, a decrease of 8.2% from the October 15th total of 40,100 shares. Based on an average daily volume of 11,400 shares, the short-interest ratio is presently 3.2 days.

Conduit Pharmaceuticals Price Performance

Shares of NASDAQ:CDTTW traded down $0.00 on Monday, hitting $0.01. The company had a trading volume of 7,417 shares, compared to its average volume of 15,710. The stock has a 50 day moving average price of $0.01 and a 200 day moving average price of $0.03. Conduit Pharmaceuticals has a 1-year low of $0.01 and a 1-year high of $0.16.

Conduit Pharmaceuticals Company Profile

Conduit Pharmaceuticals Inc, a clinical-stage specialty biopharmaceutical company, develops pharmaceutical products that provides unmet medical needs in the areas of autoimmune diseases and idiopathic male infertility. Its pipeline includes AZD1656, which has completed Phase I trials for the treatment of type 2 diabetes, renal transplant, Hashimoto's thyroiditis and Grave's disease, uveitis, and preterm labor; and AZD5904, which has completed Phase I clinical trials for the treatment of idiopathic male infertility.